By 
Depression is a serious mental illness that can take a toll on every aspect of a person’s life. If you or someone you love is struggling with depression, it’s important to know that there are treatment options available. Spravato® is a new FDA-approved medication that has shown promise for treatment-resistant chronic depression. In this article, we’ll explore everything you need to know about Spravato® so you can make an informed decision about whether it’s right for you.
What is Spravato®?
Spravato® (Esketamine) is a medication that belongs to a class of drugs known as NMDA receptor antagonists. It’s approved for use in adults with treatment-resistant depression, which means that other medications haven’t worked for them. Spravato® is available as a nasal spray, and it’s typically used alongside an antidepressant medication. You’ll need to be monitored closely by a healthcare professional while you’re taking Spravato®. So, if you’re considering this medication, it’s important to consult with a reputable spravato treatment center in Annapolis to make sure that you have a good support system in place. Also, because Spravato® is a new medication, there’s still more research that needs to be done, and you’ll want to be sure that you’re comfortable with the procedure before you start taking it.
What are the Benefits of Spravato®?
There are several potential benefits of Spravato®, including the fact that it’s a fast-acting medication. In clinical trials, some people who took Spravato® reported feeling better within two days. And because it’s a nasal spray, it’s easy to take and doesn’t require an injection. Additionally, Spravato® has been found to be effective for people who haven’t responded well to other medications. So, if you’ve tried other antidepressants without success, Spravato® may be worth considering.
How Does Spravato® Work?
Spravato® works by increasing levels of a chemical called glutamate in the brain. Glutamate is involved in nerve cell signaling, and it’s thought that increasing levels of glutamate can help to improve mood. Spravato® is thought to work faster than other antidepressants because it goes directly to the brain and starts working immediately. It is administered two times a week for four weeks, which is then followed by once a week for four weeks. After that, the maintenance dose is determined by the provider, which is typically either once a week or every two weeks. Overall, ketamine treatment in Annapolis is a promising new medication for treatment-resistant depression, and it may be worth considering if other medications haven’t worked for you.
Wrapping Up
There you have it! That’s everything you need to know about Spravato® in order to make an informed decision about whether it’s right for you. So, if you or someone you love is struggling with treatment-resistant depression, be sure to ask your healthcare provider about Spravato®. Thanks for reading!
Comments